Salona Global Medical Device Corporation
Salona Global Medical Device — Investor Presentation (July 2022)
13 slides from Salona Global Medical Device's investor presentation, Jul 29, 2022
Slide 1: Corporate Presentation
CORPORATE PRESENTATION TSXV: SGMD AUGUST, 2022 SALONA GLOBAL MEDICAL DEVICE CORPORATION
Slide 2: Important: You Must Read Before Continuing
SD MPorTANT GE YOU MUST READ BEFORE CONTINUING DISCLAIMER: This presentation (the "Presentation’) about Salona Medical Device Corporation (‘Salona” or the “Company’) is dated as of July 14, 2022 tis Information in a summary form and does not purport to be complete. It is not intended to be relied up
Slide 3: You Must Read Before Continuing
ee YOU MUST READ BEFORE CONTINUING ‘August 2022 | Page 3
Slide 4: The Recovery Science Market
THE RECOVERY SCIENCE MARKET THE $30B+ AND GROWING RECOVERY SCIENCE & MEDICAL DEVICE INDUSTRY HAS CONSISTENTLY. OUTPERFORMED THE MARKET AVERAGE (1) + 16 MILLION REGISTERED PHYSICAL THERAPISTS (PT) WORLDWIDE + 35 MILLION UNIQUE PATIENTS PER WEEK OR ABOUT 15% OF THE US ADULT POPULATION (2) + GROWING MA
Slide 5: Products
PRODUCTS PREVENTION + Specialty Supports* + Athletic Braces + Diabetic Shoes tS * Wearables* + Fall Prevention* TREATMENT + Muscle Stimulation* * Wound Care Devices* + Bone Growth Stimulators* * DVT Devices* “TENS & NMES* August 2022 | Page S —. REHABILITATION + Pre-op Devices + Compression* + Ergon
Slide 6: Management Team
MANAGEMENT TEAM FINANCIAL ADVISORS Former Chairman and Vice Chairman for Patient Home Monitoring (PHM), ‘now two companies lsted on the Nasdaq, ‘Viemed and Quipt LEs Cross EXECUTIVE CHAIRMAN. JETHRO ROTHE-KUSHEL ANCIAL COM SCOTT ROGOW KEN ZISHOLZ MELISSA POLESKY- SALES CHANNEL MEYROWITZ GREENWALD R&
Slide 7: Foundations for a Long Term Business
FOUNDATIONS FOR A LONG TERM BUSINESS GROWING MARKET PRODUCTS THAT SELL STRONG TEAM Experienced and knowledgeable management team/advisors with a strong track record Large, growing and Innovative, IP- well-defined market protected products for recovery scien: that improve globally patient care Optima
Slide 8: Vertical Integration
VERTICAL INTEGRATION Capturing “Top-to-Bottom’ Margins Through its Subsidiaries "DD. inn pumpees Simbex INTERNAL SALES BRAND MANUFACTURING RESEARCH 4 DEVELOPMENT
Slide 9: Sales & Distribution Network
& | Salona Global SALES & DISTRIBUTION NETWORK Robust distribution network to athletic trainers and physical therapists: v 30+ reps v 30+ states ¥ 400+ products ‘August 2022 | Page 9 1 LASER
Slide 10: Growth Plan
GROWTH PLAN Capitalize on extensive industry contacts drive five engines of revenue and profit growth: 1._M&A; A deep pipeline of potential acquisition targets 2. Product Development: Five products under development 3. Product IP Acquisition: Sourcing under-valued IP that can quickly be productized
Slide 11: SGMD Q1 Headlines
SGMD Q17 HEADLINES Fiscal Q1 (Ending May 31, 2022) REVENUES 152% Revenue growth in less than a year, from $3,973,773 in Q2 2021 to $10,048,548 in QI 2022 Annualized (May 2022) run-rate of $47,900,000 PROFITS 202% gross profit growth in less than a year from $1,204,171 in Q2 2021 to $3,642,265 in 212
Slide 12: Revenue Growth and Gross Margin Expansion
Salona Global stom 4am APPROX. 64M ‘APPROX. 90M Revenue Growth and Gross Margin Expansion $2398 530120 se 29337 $3978 save ‘August 2022 | Page 12 sua8 14% $2679 coe $39.12 238% s2750M 247% s2asam 243% seam
Slide 13: Thank You
0000 THANK = iM [email protected] YOU & 1 (800) 760-6826 www.salonaglobal.com e000 2022
Salona Global Medical Device — Investor Presentation (July 2022) on 6ix